Recents in Beach

header ads

Donald Trump says he's taking malaria drug to protect against virus

Donald Trump says he's taking malaria drug to protect against virus 

President Donald Trump said Monday that he's taking a malaria drug to guard against the new coronavirus, despite warnings from his own government that it should only be administered for COVID-19 during a hospital or research setting due to potentially fatal side effects.

Donald Trump says he's taking malaria drug to protect against virus
Donald Trump says he's taking malaria drug to protect against virus 

 Trump told reporters he has been taking the drug, hydroxychloroquine, and a zinc supplement daily "for a few of week and a half now." Trump spent weeks pushing the drug as a possible cure or prophylaxis for COVID-19 against the cautionary advice of the varied of his administration's top medical professionals. The drug has the potential to cause significant side effects in some patients and has not been shown to combat the new coronavirus.

 Trump said his doctor didn't recommend the drug to him, but he requested it from the White resident . "I started taking it, because i feel it's good," Trump said.

 "I've heard many excellent stories." The White resident , Dr Sean Conley, said during a handout released through the White House press office that, after "numerous discussio s" with Trump about the evidence for and against using hydroxychloroquine, "we concluded the potential enjoy treatment outweighed the relative risks."

 The Food and Drug Administration warned health professionals last month that the drug shouldn't be wont to treat COVID-19 outside of hospital or research settings, due to sometimes fatal side effects. Regulators issued the alert for the drug, which may even be wont to treat lupus and arthritis, after receiving reports of cardiac rhythm problems, including deaths, from poison control centers and other health providers. 

Trump dismissed reports of side effects, saying, "All I can tell you is, thus far I seem to be OK." a minimum of two White House staffers tested positive for COVID-19 earlier this month, sparking concerns about the steps taken by the administration to guard the president and sending president Mike Pence and other officials into varying sorts of self-isolation. The White House has since mandated that those within the West Wing wear face coverings and has introduced daily testing for the virus for the president, president and people they're available in close contact with. Trump says he continues to ascertain negative for the coronavirus.

 Trump last underwent an "interim" checkup during a November visit to Reed National Military center that wasn't noted on his public schedule. His last complete physical happened in February 2019. 
Several prominent doctors said they worried that folks would infer from Trump's example that the drug works or is safe. "There is no evidence that hydroxychloroquine is effective for the treatment or the prevention of COVID-19," said Dr Patrice Harris, president of the American Medical Association.

 "The results so far aren't promising." People shouldn't infer from Trump's example "that it's an approved approach or proven," because it's not , said Dr David Aronoff, infectious diseases chief at Vanderbilt University center in Nashville. Hydroxychloroquine can cause potentially serious cardiac rhythm problems even in healthy people, but "it's hard to infer" that Trump's artery plaque, revealed in tests from his 2018 physical, makes the drug especially dangerous for him, Aronoff said. 

White House officials didn't say whether the other administration officials were also taking the drug. Trump said he took hydroxychloroquine with an "original dose" of the antibiotic azithromycin. The president has repeatedly pushed the utilization of the drug with or without the azithromycin, but no large, rigorous studies have found them safe or effective for preventing or treating COVID-19.

 Two large observational studies, each involving around 1,400 patients in ny , recently found no enjoy hydroxychloroquine. Two new ones published Thursday within the medical journal BMJ reached an equivalent conclusion.

 One, by French researchers, gave 84 hospitalised patients the drug and 97 others the standard care. there are not any differences within the probabilities of death, need for medical care or developing severe illness. the opposite study from China was a stricter test: 150 adults hospitalised with mild or moderate illness were randomly assigned to urge hydroxychloroquine or usual care. 

The drug made no difference in rates of clearing the virus or time to relief of symptoms, which they brought more side effects.

 In April, the National Institutes of Health launched a study testing hydroxychloroquine versus a placebo drug in 500 hospitalised COVID-19 patients. Last week, NIH announced another study to work out if hydroxychloroquine plus azithromycin can prevent hospitalization or death in people with mild to moderate illness. 

About 2,000 U.S. adults with confirmed coronavirus infections and symptoms like fever, cough or shortness of breath will get the drugs or placebo pills. US prescriptions for hydroxychloroquine surged roughly 80% in March to quite 830,000 compared with same period within the prior year, consistent with data tracking firm IQVIA. That jump in prescribing came before the federal accepted nearly 30 million doses of the drug donated to the strategic national stockpile by foreign drugmakers. Since then, many those tablets are shipped to US hospitals nationwide to be used treating patients with COVID-19.

Post a Comment

0 Comments